Prescribing Pre-Exposure Prophylaxis (PrEP) for HIV in WA general practice

On-demand recorded 30 Jun 2020

This webinar explores the strategies available for the prevention of HIV transmission, focusing on pre-exposure prophylaxis (PrEP). A landmark in HIV prevention drugs, PrEP (tenofovir with emtricitabine) is approved for use on the Pharmaceutical Benefits Scheme.

This webinar covers how to screen for PrEP eligibility, how to prescribe PrEP, and the best practice for monitoring patients on PrEP.

Delivered in partnership with the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM).

Learning outcomes

• Describe different HIV prevention strategies
• Explain different options for PrEP dosing
• Use the PrEP decision making tool to manage patients on PrEP
• Explain the effectiveness and appropriate use of PrEP/PEP to patients

This event attracts 2 CPD points

Facilitator

Dr Rafal Francikiewicz
GP Facilitator

Hosts

Sharon Safstrom
CPD Program Coordinator, Faculties

Lisa Francis
Membership, Marketing and Events Coordinator, Faculties

Presenters

Dr Ric Chaney
General Practitioner

Medical Lead

Dr Rafal Francikiewicz
GP Facilitator